BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34561886)

  • 41. Use of Topical Sirolimus (Rapamycin) for Treating Confluent and Reticulated Papillomatosis.
    Kurtyka DJ; Burke KT; DeKlotz CMC
    JAMA Dermatol; 2021 Jan; 157(1):121-123. PubMed ID: 33175118
    [No Abstract]   [Full Text] [Related]  

  • 42. Confluent and reticulated papillomatosis. Treatment with etretinate.
    Baalbaki SA; Malak JA; al-Khars MA
    Arch Dermatol; 1993 Aug; 129(8):961-3. PubMed ID: 8352619
    [No Abstract]   [Full Text] [Related]  

  • 43. Successful treatment of confluent and reticulated papillomatosis with a combination of doxycycline and topical tretinoin.
    Ting IPL; Kiing JW
    J R Coll Physicians Edinb; 2024 Mar; 54(1):59-61. PubMed ID: 38357752
    [No Abstract]   [Full Text] [Related]  

  • 44. Differentiating confluent and reticulated papillomatosis from acanthosis nigricans.
    Park YJ; Kang HY; Lee ES; Kim YC
    J Cutan Pathol; 2015 Dec; 42(12):944-952. PubMed ID: 26264983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Confluent and reticulated papillomatosis: response to tazarotene.
    Bowman PH; Davis LS
    J Am Acad Dermatol; 2003 May; 48(5 Suppl):S80-1. PubMed ID: 12734485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Confluent and reticulated papillomatosis responsive to minocycline.
    Shimizu S; Han-Yaku H
    Dermatology; 1997; 194(1):59-61. PubMed ID: 9031794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Confluent and reticulated papillomatosis: failure of response to calcipotriol and coincidental association with vascular mottling.
    Basak PY; Baysal V; Ozcanli C
    J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):591-2. PubMed ID: 11843226
    [No Abstract]   [Full Text] [Related]  

  • 48. Confluent and reticulated papillomatosis: treatment with minocycline.
    Sassolas B; Plantin P; Guillet G
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):501-2. PubMed ID: 1564161
    [No Abstract]   [Full Text] [Related]  

  • 49. Confluent and reticulated papillomatosis without papillomatosis.
    Díez E; Alonso LM; Zambrano B; de Eusebio E
    J Am Acad Dermatol; 2005 May; 52(5):E8. PubMed ID: 15858464
    [No Abstract]   [Full Text] [Related]  

  • 50. [Confluent and reticulate papillomatosis. Successful therapy with azithromycin].
    Weigl LB; Beham A; Schnopp C; Möhrenschlager M; Abeck D
    Hautarzt; 2001 Oct; 52(10 Pt 2):947-9. PubMed ID: 11715390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Confluent and reticulated papillomatosis of Gougerot and Carteaud. Treatment by minocycline].
    Petit A; Evenou P; Civatte J
    Ann Dermatol Venereol; 1989; 116(1):29-30. PubMed ID: 2712480
    [No Abstract]   [Full Text] [Related]  

  • 52. [Confluent and reticulated Gougerot and Carteaud's papillomatosis].
    Andriantsinjovina T; Antunes A; Truchetet F
    Ann Dermatol Venereol; 2003 May; 130(5):581-2. PubMed ID: 12843845
    [No Abstract]   [Full Text] [Related]  

  • 53. Confluent and reticulated papillomatosis on the arm successfully treated with minocycline.
    Kim MR; Kim SC
    J Dermatol; 2010 Aug; 37(8):749-50. PubMed ID: 20649722
    [No Abstract]   [Full Text] [Related]  

  • 54. Confluent and reticulated papillomatosis: Case series of 3 patients from Kedah, Malaysia and literature review.
    Lee SW; Loo CH; Tan WC
    Med J Malaysia; 2018 Oct; 73(5):338-339. PubMed ID: 30350820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Confluent and Reticulated Papillomatosis of Gougerot and Carteaud: A Case Report and Review of the Literature.
    Banjar TA; Abdulwahab RA; Al Hawsawi KA
    Cureus; 2022 Apr; 14(4):e24557. PubMed ID: 35651451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case of maxacalcitol-resistant confluent and reticulated papillomatosis successfully treated with minocycline.
    Yamamoto Y; Kadota M; Nishimura Y
    J Dermatol; 2006 Mar; 33(3):223-4. PubMed ID: 16620232
    [No Abstract]   [Full Text] [Related]  

  • 57. Confluent and reticulated papillomatosis (Gougerot-Carteaud) treated with tetracyclines.
    Angeli-Besson C; Koeppel MC; Jacquet P; Andrac L; Sayag J
    Int J Dermatol; 1995 Aug; 34(8):567-9. PubMed ID: 7591440
    [No Abstract]   [Full Text] [Related]  

  • 58. Calcipotriol treatment of confluent and reticulated papillomatosis (Gougerot-Carteaud syndrome).
    Carrozzo AM; Gatti S; Ferranti G; Primavera G; Vidolin AP; Nini G
    J Eur Acad Dermatol Venereol; 2000 Mar; 14(2):131-3. PubMed ID: 10972100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concomitant confluent and reticulated papillomatosis and acanthosis nigricans in patients with skin of color and need for early interventions for insulin resistance.
    Enwereji N; Mallett J
    Int J Womens Dermatol; 2023 Dec; 9(4):e119. PubMed ID: 37927368
    [No Abstract]   [Full Text] [Related]  

  • 60. Case of minocycline-effective confluent and reticulated papillomatosis with unusual location on forehead.
    Kim BS; Lim HJ; Kim HY; Lee WJ; Lee SJ; Kim DW
    J Dermatol; 2009 Apr; 36(4):251-3. PubMed ID: 19348668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.